559 related articles for article (PubMed ID: 14680965)
21. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
Abd-Jamil J; Cheah CY; AbuBakar S
Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
[TBL] [Abstract][Full Text] [Related]
22. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates.
Bernardo L; Izquierdo A; Alvarez M; Rosario D; Prado I; López C; Martínez R; Castro J; Santana E; Hermida L; Guillen G; Guzmán MG
Antiviral Res; 2008 Nov; 80(2):194-9. PubMed ID: 18602424
[TBL] [Abstract][Full Text] [Related]
24. Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.
Tripathi NK; Shrivastava A; Biswal KC; Rao PV
Appl Microbiol Biotechnol; 2012 Sep; 95(5):1179-89. PubMed ID: 22562165
[TBL] [Abstract][Full Text] [Related]
25. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
[TBL] [Abstract][Full Text] [Related]
26. Expression, purification and immunodetection of a recombinant fragment (residues 179-281) of the G protein from rabies virus ERA strain.
Bassi EJ; Vernal J; Zanluca C; Terenzi H; Zanetti CR
Protein Expr Purif; 2008 Jun; 59(2):309-13. PubMed ID: 18406167
[TBL] [Abstract][Full Text] [Related]
27. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes.
Erb SM; Butrapet S; Moss KJ; Luy BE; Childers T; Calvert AE; Silengo SJ; Roehrig JT; Huang CY; Blair CD
Virology; 2010 Oct; 406(2):328-35. PubMed ID: 20708768
[TBL] [Abstract][Full Text] [Related]
28. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
[TBL] [Abstract][Full Text] [Related]
29. Production of IgM specific recombinant dengue multiepitope protein for early diagnosis of dengue infection.
Tripathi NK; Shrivastva A; Pattnaik P; Parida M; Dash PK; Gupta N; Jana AM; Rao PV
Biotechnol Prog; 2007; 23(2):488-93. PubMed ID: 17256968
[TBL] [Abstract][Full Text] [Related]
30. Optimized sequential purification protocol for in vivo site-specific biotinylated full-length dengue virus capsid protein.
Chong MK; Parthasarathy K; Yeo HY; Ng ML
Protein Eng Des Sel; 2013 May; 26(5):377-87. PubMed ID: 23479673
[TBL] [Abstract][Full Text] [Related]
31. A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.
Valdés I; Bernardo L; Gil L; Pavón A; Lazo L; López C; Romero Y; Menendez I; Falcón V; Betancourt L; Martín J; Chinea G; Silva R; Guzmán MG; Guillén G; Hermida L
Virology; 2009 Nov; 394(2):249-58. PubMed ID: 19783271
[TBL] [Abstract][Full Text] [Related]
32. Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response.
dos Santos FB; Miagostovich MP; Nogueira RM; Schatzmayr HG; Riley LW; Harris E
Am J Trop Med Hyg; 2004 Aug; 71(2):144-52. PubMed ID: 15306702
[TBL] [Abstract][Full Text] [Related]
33. Purification of a secreted form of recombinant rabies virus glycoprotein: comparison of two affinity tags.
Wojczyk BS; Czerwinski M; Stwora-Wojczyk MM; Siegel DL; Abrams WR; Wunner WH; Spitalnik SL
Protein Expr Purif; 1996 Mar; 7(2):183-93. PubMed ID: 8812859
[TBL] [Abstract][Full Text] [Related]
34. Recombinant multiepitope protein for early detection of dengue infections.
Anandarao R; Swaminathan S; Fernando S; Jana AM; Khanna N
Clin Vaccine Immunol; 2006 Jan; 13(1):59-67. PubMed ID: 16426001
[TBL] [Abstract][Full Text] [Related]
35. Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein.
Amorim JH; Porchia BF; Balan A; Cavalcante RC; da Costa SM; de Barcelos Alves AM; de Souza Ferreira LC
J Virol Methods; 2010 Aug; 167(2):186-92. PubMed ID: 20399232
[TBL] [Abstract][Full Text] [Related]
36. Soluble expression in Escherichia coli of murine endogenous retroviral transmembrane envelope protein having immunosuppressive activity.
Kim KS; Kim KH; Choi SE; Yoon JW; Kang Y
Protein Expr Purif; 1999 Jun; 16(1):19-26. PubMed ID: 10336856
[TBL] [Abstract][Full Text] [Related]
37. Expression of the extracellular domain of the human heat-stable enterotoxin receptor in Escherichia coli and generation of neutralizing antibodies.
Nandi A; Mathew R; Visweswariah SS
Protein Expr Purif; 1996 Sep; 8(2):151-9. PubMed ID: 8812850
[TBL] [Abstract][Full Text] [Related]
38. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
39. Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cells.
Verma SK; Gupta N; Pattnaik P; Babu JP; Rao PV; Kumar S
Protein Pept Lett; 2009; 16(11):1334-41. PubMed ID: 20001924
[TBL] [Abstract][Full Text] [Related]
40. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.
Purdy DE; Chang GJ
Virology; 2005 Mar; 333(2):239-50. PubMed ID: 15721358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
